MediciNova
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of MediciNova generated cash of -$7,431,038, which is more than the previous year. Cash used in financing activities reached the amount of $0 last year. Net change in cash is therefore $32,493,949.
Cash Flow
| 2014 | 816.52K | -3.52K | 4.16M |
|---|---|---|---|
| 2015 | -7.15M | -2.32K | 17.56M |
| 2016 | -6.54M | -84.48K | 8.66M |
| 2017 | -6.92M | -84.48M | 10.79M |
| 2018 | -9.11M | 626.32K | 42.80M |
| 2019 | -9.12M | -11.27K | 10.61M |
| 2020 | -10.82M | -36.49K | 7.10M |
| 2021 | -9.38M | -28.73K | 20.77M |
| 2022 | -12.91M | -40.00M | 7.92K |
| 2023 | -7.43M | 39.90M | 0 |
MNOV Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 18.50M | 71.43M | 60.03M | 63.79M | 62.31M | 27.99M | 24.11M | 22.07M | 11.66M | 6.70M |
Operating activities | ||||||||||
Net income | -8.57M | -14.06M | -10.13M | -13.85M | -12.94M | -14.67M | -11.16M | -10.86M | -8.84M | -9.19M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 20.29K | 17.70K | 26.14K | 21.34K | 23.94K | 25.88K | 28.09K | 14.12K | 26.70K | 40.18K |
Stock-based compensation expense | 710.71K | 642.52K | 1.71M | 3.17M | 4.11M | 0 | 4.47M | 3.97M | 2.02M | 1.63M |
| Deferred income tax benefit | 710.71K | 642.52K | 1.71M | 3.17M | 4.11M | 0 | 4.47M | 3.97M | 2.02M | 1.63M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | -111.68K | 242.06K | 175.49K | -284.53K | 6.00B |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.55B |
Accounts payable | 19.23K | 329.01K | -1.02M | -224.31K | 194.09K | -663.67K | 1.24M | 127.37K | -181.93M | 551.95M |
Cash generated by operating activities | -7.43M | -12.91M | -9.38M | -10.82M | -9.12M | -9.11M | -6.92M | -6.54M | -7.15M | 816.52K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -59.87M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -21.29K | -5.01K | -28.73K | -36.49K | -11.27K | -10.2K | 0 | -84.48K | -2.32K | -3.52K |
Acquisitions Net | 0 | 5.01M | 0 | 0 | 0 | 636.52K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 39.90M | -40.00M | -28.73K | -36.49K | -11.27K | 626.32K | -84.48M | -84.48K | -2.32K | -3.52K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 7.92K | 20.89M | 7.29M | 10.87M | 42.75M | 10.71M | 8.57M | 17.47M | 3.79M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 0 | 7.92K | 20.77M | 7.10M | 10.61M | 42.80M | 10.79M | 8.66M | 17.56M | 4.16M |
Net Change In Cash | 32.49M | -52.92M | 11.39M | -3.75M | 1.47M | 34.32M | 3.87M | 2.04M | 10.40M | 4.96M |
Cash at end of period | 50.99M | 18.50M | 71.43M | 60.03M | 63.79M | 62.31M | 27.99M | 24.11M | 22.07M | 11.66M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |